You can buy or sell Eisai and other stocks, options, and ETFs commission-free!
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. Read More The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan. ESALY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com). The listed name for ESALY is Eisai Co Ltd American Depositary Shares.
52 Week High
52 Week Low
Eisai to Present Latest Data on Pipeline Assets in the Area of Alzheimer's Disease and Dementia at the 13th Clinical Trials on Alzheimer's Disease Conference
Media Inquiries: Public Relations Department, Eisai Co., Ltd. +81-(0)3-3817-5120 TOKYO, Oct 28, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that th